19-11447525-AGAGGAGGAGGAGGAGGAG-AGAGGAGGAGGAGGAGGAGGAGGAGGAGGAG
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP3BS2_Supporting
The NM_001289104.2(PRKCSH):c.957_968dupGGAGGAGGAGGA(p.Glu320_Glu323dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000040 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000042 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PRKCSH
NM_001289104.2 disruptive_inframe_insertion
NM_001289104.2 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.52
Genes affected
PRKCSH (HGNC:9411): (PRKCSH beta subunit of glucosidase II) This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001289104.2
BS2
High AC in GnomAd4 at 6 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000401 AC: 6AN: 149518Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
6
AN:
149518
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000418 AC: 60AN: 1434308Hom.: 0 Cov.: 0 AF XY: 0.0000533 AC XY: 38AN XY: 712784
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
60
AN:
1434308
Hom.:
Cov.:
0
AF XY:
AC XY:
38
AN XY:
712784
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000401 AC: 6AN: 149518Hom.: 0 Cov.: 0 AF XY: 0.0000550 AC XY: 4AN XY: 72784
GnomAD4 genome
AF:
AC:
6
AN:
149518
Hom.:
Cov.:
0
AF XY:
AC XY:
4
AN XY:
72784
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Polycystic liver disease 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 04, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at